Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries

Published:2014-06-27 Issue:3 Volume:8 Page:382-394
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Dan Yock Young,Wong John B.,Hamid Saeed S.,Han Kwang-Hyub,Jia Ji Dong,Liu Chun-Jen,Piratvisuth Teerha,Lok Anna S. F.,Lim Seng Gee

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-014-9549-1.pdf

Reference27 articles.

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis. 2004;11(2):97–107

2. Lesmana LALN-Y, Mahachai V, Phiet PH, Suh DJ, Yao GB, Hepatitis B. Overview of the burden of disease in the Asia-Pacific region. Liver Int. 2006;26(s2):3–10

3. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology (Baltimore, Md.) 2009;50(3):661–662. Epub 2009/08/29

4. European Association For The Study Of The L. EASL. Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol. 2009;50(2):227–242 Epub 2008/12/05

5. Liaw Y-F, Kao JH, Piratvisuth T, Chan HLY, Chien R-N, Liu C-J, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hep Int. 2012;6(3):531–561 Epub 17 May 2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression;Clinical and Translational Gastroenterology;2021-02

2. Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection;Journal of the Formosan Medical Association;2020-01

3. Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature Review;PharmacoEconomics - Open;2019-08-19

4. Strategies for Global Elimination of Chronic HBV Infection: 2019 Update;Current Hepatology Reports;2019-08-05

5. Factors affecting mortality and resource use for hospitalized patients with cirrhosis;Medicine;2017-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3